Market Currents
More on WuXi Pharmatech (WX): Q3 beats on all counts as total revenue jumps 21% Y/Y. Net profit...
-
Monday, November 12, 2012, 5:22 PM ETMore on WuXi Pharmatech (WX): Q3 beats on all counts as total revenue jumps 21% Y/Y. Net profit rose 3.2% as margins were boosted by a one-off gain and its top line benefited from higher lab-services revenue. The company also upped the low end of its FY revenue guidance, now seeing revenue coming in between $495M to $498M. For the current quarter, revenue is expected to be around $121M to $124M, shy of the Street's $125M consensus estimate.
Other date
Latest Global Articles
